tm
Seeing Is Believing
tm
Seeing Is Believing
ANEB is currently covered by 2 analysts with an average price target of $5.96. This is a potential upside of $4.38 (277.22%) from yesterday's end of day stock price of $1.58.
Anebulo Pharmaceuticals's activity chart (see below) currently has 3 price targets and 7 ratings on display. The stock rating distribution of ANEB is 100% BUY.
Highest price target for ANEB is $3, Lowest price target is $2, average price target is $6.
Most recent stock forecast was given by ROBERT WASSERMAN from BENCHMARK on 19-Nov-2024. First documented stock forecast 14-Feb-2023.
Currently out of the existing stock ratings of ANEB, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$8
6 months 28 days ago
(19-Nov-2024)
0/4 (0%)
$6.02 (304.04%)
Buy
$6
$4.61 (331.65%)
$6
1 years 8 months 22 days ago
(25-Sep-2023)
0/2 (0%)
$2.73 (83.49%)
What is ANEB (Anebulo Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ANEB (Anebulo Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on ANEB (Anebulo Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ANEB (Anebulo Pharmaceuticals)?
Which analyst is the currently most bullish on ANEB (Anebulo Pharmaceuticals)?
Which analyst is the currently most reserved on ANEB (Anebulo Pharmaceuticals)?
